Trial Profile
A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 13 Sep 2022 Status changed from active, no longer recruiting to completed.
- 15 Jul 2022 Planned End Date changed from 1 Aug 2022 to 1 May 2024.
- 15 Jul 2022 Status changed from recruiting to active, no longer recruiting.